HIGHLIGHTS
- who: Faruk Tas from the Institute of Oncology, Istanbul University, Istanbul, Turkey have published the paper: Clinical Study Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors, in the Journal: (JOURNAL) of 10/Oct/2011
- what: This study was conducted to investigate the metastatic behavior timing patterns survival and influencing factors in MM. 214 patients with MM were evaluated retrospectively.
SUMMARY
Despite recent advances in the understanding of oncogenic mechanisms and therapeutic interventions, the median survival in patients with metastatic disease does not go beyond 12 months. Two hundred and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.